| Stem definition | Drug id | CAS RN |
|---|---|---|
| anti-infectives, sulfonamides | 2512 | 144-82-1 |
| Dose | Unit | Route |
|---|---|---|
| 4 | g | O |
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 4 | Benet LZ, Broccatelli F, Oprea TI |
| S (Water solubility) | 0.61 mg/mL | Bocci G, Oprea TI, Benet LZ |
| EoM (Fraction excreted unchanged in urine) | 86 % | Benet LZ, Broccatelli F, Oprea TI |
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 211.38 ยตM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Oct. 28, 1953 | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | B05CA04 | BLOOD AND BLOOD FORMING ORGANS BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS IRRIGATING SOLUTIONS Antiinfectives |
| ATC | D06BA04 | DERMATOLOGICALS ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE Sulfonamides |
| ATC | J01EB02 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE SULFONAMIDES AND TRIMETHOPRIM Short-acting sulfonamides |
| ATC | S01AB01 | SENSORY ORGANS OPHTHALMOLOGICALS ANTIINFECTIVES Sulfonamides |
| MeSH PA | D000890 | Anti-Infective Agents |
| CHEBI has role | CHEBI:33281 | antibiotics |
| CHEBI has role | CHEBI:35441 | antiinfective agents |
| CHEBI has role | CHEBI:50502 | dihydropteroate synthase inhibitors |
| CHEBI has role | CHEBI:88188 | allergenic drug |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Acute otitis media | indication | 3110003 | |
| Haemophilus Influenzae Acute Otitis Media | indication | 19021002 | |
| Shigellosis | indication | 36188001 | |
| Klebsiella cystitis | indication | 60867007 | |
| Escherichia coli urinary tract infection | indication | 301011002 | |
| Proteus urinary tract infection | indication | 301012009 | |
| Bacterial urinary infection | indication | 312124009 | |
| Infective otitis media | indication | 312218008 | |
| Pneumocystosis jiroveci pneumonia | indication | 415125002 | DOID:11339 |
| Pneumocystis Carinii Pneumonia Prevention | indication | ||
| Morganella Morganii Urinary Tract Infection | indication | ||
| Streptococcus Pneumoniae Chronic Bronchitis | indication | ||
| Haemophilus Influenzae Chronic Bronchitis | indication | ||
| Renal tubular acidosis | contraindication | 1776003 | DOID:14219 |
| Respiratory acidosis | contraindication | 12326000 | |
| Hyperkalemia | contraindication | 14140009 | |
| Metabolic acidosis, normal anion gap, acidifying salts | contraindication | 18104000 | |
| Glomerulonephritis | contraindication | 36171008 | DOID:2921 |
| Acute hepatitis | contraindication | 37871000 | |
| Diabetes mellitus type 2 | contraindication | 44054006 | DOID:9352 |
| Uremia | contraindication | 44730006 | DOID:4676 |
| Diabetes mellitus type 1 | contraindication | 46635009 | DOID:9744 |
| Acute nephropathy | contraindication | 58574008 | |
| Hepatic failure | contraindication | 59927004 | |
| Decreased respiratory function | contraindication | 80954004 | |
| Hyponatremia | contraindication | 89627008 | |
| Gout | contraindication | 90560007 | DOID:13189 |
| Kidney disease | contraindication | 90708001 | DOID:557 |
| Anemia due to enzyme deficiency | contraindication | 111577008 | |
| Deficiency of glucose-6-phosphate dehydrogenase | contraindication | 124134002 | DOID:2862 |
| Disease of blood AND/OR blood-forming organ | contraindication | 191124002 | DOID:74 |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Disorder of electrolytes | contraindication | 237840007 | |
| Pregnancy, function | contraindication | 289908002 | |
| Primary adrenocortical insufficiency | contraindication | 373662000 | |
| Pseudomembranous enterocolitis | contraindication | 397683000 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Recurrent Calcium Renal Calculi | contraindication |
| Species | Use | Relation |
|---|---|---|
| Cats | Urinary tract infections | Indication |
| Cats | Management of complications resulting from surgical manipulations of the urinary tract | Indication |
| Dogs | Urinary tract infections | Indication |
| Dogs | Management of complications resulting from surgical manipulations of the urinary tract | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Mesulfin Tablets | Zoetis Inc. | 2 |
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 5.34 | acidic |
| pKa2 | 2.81 | Basic |
| pKa3 | 2.17 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Dihydropteroate synthase | Enzyme | INHIBITOR | WOMBAT-PK | CHEMBL |
| ID | Source |
|---|---|
| 4018493 | VUID |
| N0000146815 | NUI |
| D00870 | KEGG_DRUG |
| 4018493 | VANDF |
| C0038687 | UMLSCUI |
| CHEBI:9331 | CHEBI |
| CHEMBL1191 | ChEMBL_ID |
| DB00576 | DRUGBANK_ID |
| D013419 | MESH_DESCRIPTOR_UI |
| 5328 | PUBCHEM_CID |
| 12683 | IUPHAR_LIGAND_ID |
| 529 | INN_ID |
| 25W8454H16 | UNII |
| 10179 | RXNORM |
| 5525 | MMSL |
| d01090 | MMSL |
| 002822 | NDDF |
| 387389006 | SNOMEDCT_US |
| 70254000 | SNOMEDCT_US |
None